Publication Date
In 2025 | 0 |
Since 2024 | 1 |
Since 2021 (last 5 years) | 1 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 4 |
Descriptor
Children | 4 |
Metabolism | 4 |
Drug Therapy | 3 |
Physiology | 3 |
Symptoms (Individual… | 3 |
Autism | 2 |
Behavior Problems | 2 |
Child Behavior | 2 |
Foreign Countries | 2 |
Mental Retardation | 2 |
Outcomes of Treatment | 2 |
More ▼ |
Source
International Journal of… | 1 |
Journal of Autism and… | 1 |
Journal of Child Psychology… | 1 |
Research in Developmental… | 1 |
Author
Abdulbaki Akyildiz | 1 |
Aman, Michael G. | 1 |
Arnold, L. Eugene | 1 |
Baird, Gillian | 1 |
Bernard, Sarah | 1 |
Chadwick, Oliver | 1 |
Early, Maureen C. | 1 |
Erickson, Craig A. | 1 |
Fatma Coskun | 1 |
Fatma Hümeyra Yerlikaya | 1 |
Golaszewski, Ania | 1 |
More ▼ |
Publication Type
Journal Articles | 4 |
Reports - Research | 4 |
Education Level
Audience
Location
Turkey | 1 |
United Kingdom | 1 |
Laws, Policies, & Programs
Assessments and Surveys
Aberrant Behavior Checklist | 4 |
Childhood Autism Rating Scale | 1 |
Conners Rating Scales | 1 |
What Works Clearinghouse Rating
Serdar Karatoprak; Sadettin Burak Acikel; Abdulbaki Akyildiz; Fatma Coskun; Fatma Hümeyra Yerlikaya – International Journal of Developmental Disabilities, 2024
Background: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder, the etiology of which has not been clearly determined yet. There is increasing evidence that synaptic and dendritic changes are involved in the etiology of ASD. The aim of this study is to determine whether serum Thrombospondin-1 and Thrombospondin-2 differ between ASD…
Descriptors: Children, Autism Spectrum Disorders, Etiology, Metabolism
Erickson, Craig A.; Wink, Logan K.; Early, Maureen C.; Stiegelmeyer, Elizabeth; Mathieu-Frasier, Lauren; Patrick, Vanessa; McDougle, Christopher J. – Journal of Autism and Developmental Disorders, 2014
Rationale: An excitatory/inhibitory (E:I) imbalance marked by enhanced glutamate and deficient gamma-aminobutyric acid (GABA) neurotransmission may contribute to the pathophysiology of autism spectrum disorders (ASD). Objectives: We report on the first single-blind placebo lead-in trial of acamprosate, a drug with putative mechanisms restoring E:I…
Descriptors: Autism, Pervasive Developmental Disorders, Drug Therapy, Metabolism
Simonoff, Emily; Taylor, Eric; Baird, Gillian; Bernard, Sarah; Chadwick, Oliver; Liang, Holan; Whitwell, Susannah; Riemer, Kirsten; Sharma, Kishan; Sharma, Santvana Pandey; Wood, Nicky; Kelly, Joanna; Golaszewski, Ania; Kennedy, Juliet; Rodney, Lydia; West, Nicole; Walwyn, Rebecca; Jichi, Fatima – Journal of Child Psychology and Psychiatry, 2013
Background: Attention deficit hyperactivity disorder is increased in children with intellectual disability. Previous research has suggested stimulants are less effective than in typically developing children but no studies have titrated medication for individual optimal dosing or tested the effects for longer than 4 weeks. Method: One hundred and…
Descriptors: Attention Deficit Hyperactivity Disorder, Children, Mental Retardation, Drug Therapy
Aman, Michael G.; Hollway, Jill A.; Leone, Sarah; Masty, Jessica; Lindsay, Ronald; Nash, Patricia; Arnold, L. Eugene – Research in Developmental Disabilities: A Multidisciplinary Journal, 2009
This study was designed to explore the placebo-controlled effects of risperidone on cognitive-motor processes, dyskinetic movements, and behavior in children receiving maintenance risperidone therapy. Sixteen children aged 4-14 years with disruptive behavior were randomly assigned to drug order in a crossover study of risperidone and placebo for 2…
Descriptors: Metabolism, Behavior Problems, Reaction Time, Hyperactivity